IgG N-glycosylation galactose incorporation ratios for the monitoring of classical galactosaemia

JIMD Reports

Volumn 27, Issue , 2016, Pages 47-53

  Stockmann, Henning ^a   Coss, Karen P ^b   Rubio Gozalbo, M Estela ^c   Knerr, Ina ^d   Fitzgibbon, Maria ^e   Maratha, Ashwini ^a   Wilson, James ^f   Rudd, Pauline ^a   Treacy, Eileen P ^a,e,g  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b GUY S HOSPITAL   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^e MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Assembly defect; Classical galactosaemia; Dietary galactose; Galactosaemia patient; Galactose intake

Indexed keywords

EID: 85052050974     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2015_490     Document Type: Chapter

References (27)

1. Bosch AM, Bakker HD, Wenniger-Prick LJ, Wanders RJ, Wijburg FA (2004) High tolerance for oral galactose in classical galactosaemia: dietary implications. Arch Dis Child 89:1034–1036
2. Charlwood J, Clayton P, Keir G, Mian N, Winchester B (1998) Defective galactosylation of serum transferrin in galactosemia. Glycobiology 8:351–357
3. Coman DJ, Murray DW, Byrne JC, Rudd PM, Bagaglia PM, Doran PD, Treacy EP (2010) Galactosemia, a single gene disorder with epigenetic consequences. Pediatric Res 67:286–292
4. Coss K, Byrne J, Coman D, Adamczyk B et al (2012) IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia. Mol Genet Metab 105:212–220
5. Coss KP, Hawkes CP, Adamczyk B et al (2013) N-glycan abnormalities in children with galactosemia. J Proteome Res 13:385–394
6. Coss K, Treacy E, Cotter E, Knerr I, Murray D, Shin Y, Doran P (2014) Systemic gene dysregulation in classical Galactosaemia: is there a central mechanism? Mol Genet Metab 113:177–187
7. Dani N, Broadie K (2012) Glycosylated synaptomatrix regulation of trans‐synaptic signalling. Dev Neurobiol 72(1):2–21
8. Freeze HH (2013) Understanding human glycosylation disorders: biochemistry leads the charge. J Biol Chem 288:6936–6945
9. Frey PA (1996) The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J 10:461–470
10. Fridovich-Keil JL, Walter JH (2008) Galactosaemia Chapter 72. The online metabolic and molecular bases of inherited disease, OMMBID. McGraw Hill, New York
11. Hughes J, Ryan S, Lambert D et al (2009) Outcomes of siblings with classical galactosemia. J Pediatr 154:721–726
12. Hutchesson AC, Murdoch-Davis C, Green A, Preece MA, Allen J, Holton JB, Rylance G (1999) Biochemical monitoring of treatment for galactosaemia: biological variability in metabolite concentrations. J Inherit Metab Dis 22:139–148
13. Jumbo-Lucioni P, Garber K, Kiel J et al (2012) Diversity of approaches to classic galactosaemia around the world: a comparison of diagnosis, intervention and outcomes. J Inherit Metab Dis 35(6):1037–1049
14. Jumbo-Lucioni P, Parkinson W, Broadie K (2014) Altered synaptic architecture and glycosylated synaptomatrix composition in a Drosophila classic galactosemia disease model. Dis Model Mech 7(12):1365–1378
15. Knerr I, Coss KP, Kratzsch J et al (2015) Effects of temporary low-dose galactose supplements in children aged 5–12 years with Classical Galactosaemia: a pilot study. Pediatr Res. doi:10.1038/pr.2015.107
16. Krabbi K, Uudelepp ML, Joost K, Zordania R, Ounap K (2011) Long-term complications in Estonian galactosemia patients with a less strict lactose-free diet and metabolic control. Mol Genet Metab 103(3):249–253
17. Lai K, Langley SD, Khwaja FW, Schmitt EW, Elsas LJ (2003) GALT deficiency causes UDP-hexose deficit in human galacto-semic cells. Glycobiology 13:285–294
18. Liu Y, Xia B, Gleason TJ, Castañeda U, He M, Berry GT, Fridovich-Keil JL (2012) N-and O-linked glycosylation of total plasma glycoproteins in galactosemia. Mol Genet Metab 106:442–454
19. Ng WG, Xu YK, Kaufman FR, Donnell GN (1989) Deficit of uridine diphosphate galactose in galactosaemia. J Inherit Metab Dis 12: 257–266
20. Ornstein KS, McGuire EJ, Berry GT, Roth S, Segal S (1992) Abnormal galactosylation of complex carbohydrates in cultured fibroblasts from patients with galactose-1-phosphate uridyltrans-ferase deficiency. Pediatr Res 31:508–511
21. Petry K, Greinix HT, Nudelman E, Eisen H, Hakomori S, Levy HL, Reichardt JK (1991) Characterization of a novel biochemical abnormality in galactosemia: deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes. Biochem Med Metab Biol 46: 93
22. Pučić M, Knežević A, Vidič J et al (2011) High throughput isolation and glycosylation analysis of IgG–variability and heritability of the IgG glycome in three isolated human populations. Mol Cell. Proteomics 10:M111.010090
23. Quintana E, Navarro-Sastre A, Hernández-Pérez JM et al (2009) Screening for congenital disorders of glycosylation (CDG): transferrin HPLC versus isoelectric focusing (IEF). Clin Biochem 42:408–415
24. Royle L, Campbell MP, Radcliffe CM, White DM et al (2008) HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem 376:1–12
25. Slepak TI, Tang M, Slepak VZ, Lai K (2007) Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model. Mol Genet Metab 92:78–87
26. Stöckmann H, Adamczyk B, Hayes J, Rudd PM (2013) Automated, high-throughput IgG-antibody glycoprofiling platform. Anal Chem 85: 8841–8849
27. Sturiale L, Barone R, Fiumara A et al (2005) Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. Glycobiology 15: 1268–1276